Induction of human umbilical Wharton's jelly-derived stem cells toward oligodendrocyte phenotype

J Mol Neurosci. 2013 Oct;51(2):328-36. doi: 10.1007/s12031-013-0094-5. Epub 2013 Sep 11.

Abstract

In this study, we examined phenotypic features of human Wharton's jelly mesenchymal stem cells-derived oligodendrocytes. We induced human WJMSCs to form OLs by signaling molecules including basic fibroblastic growth factor, platelet-derived growth factor-AA, and triiodothyronine hormone. Differentiated WJMSCs showed morphologic characteristics of an OL phenotype. Expression of surface markers and genes in oligodendrocyte precursor cells or OLs were analyzed by immunocytochemistry staining and real-time polymerase chain reaction, respectively. These results suggest that WJMSCs could be programmed to OLs and might provide a potential source for cell therapy in neurodegenerative disease.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Female
  • Fibroblast Growth Factors / pharmacology
  • Humans
  • Mesenchymal Stem Cells / cytology*
  • Mesenchymal Stem Cells / drug effects
  • Mesenchymal Stem Cells / metabolism
  • Neurogenesis*
  • Oligodendroglia / cytology*
  • Oligodendroglia / drug effects
  • Oligodendroglia / metabolism
  • Phenotype*
  • Platelet-Derived Growth Factor / pharmacology
  • Triiodothyronine / pharmacology

Substances

  • Platelet-Derived Growth Factor
  • platelet-derived growth factor A
  • Triiodothyronine
  • Fibroblast Growth Factors